Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00083421 · ClinicalTrials.gov registry record · Phase 2
Effects of ONO-2506PO in Patients With Alzheimer's Disease
A Phase 2 study, sponsored by Ono Pharma USA.
- Completed
- Registry status
- Phase 2
- Development phase
- 647
- Enrollment target
NCT00083421: Completed Phase 2 study, sponsored by Ono Pharma USA.
NCT00083421 is a Phase 2 study that has completed, run by Ono Pharma USA. The registered enrollment target is 647 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (386% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00083421, a Phase 2 study, has completed, sponsored by Ono Pharma USA.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 647 participants
- Enrollment target
Study Summary
The purpose of this study is to establish the presence of an effect of treatment with ONO-2506PO in patients with Alzheimer's Disease, based upon cognitive and global scales.
Interventions
- DRUG ONO-2506PO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 647 participants |
| Start Date | 2004-06 |
| Est. Completion | 2007-07 |
| Phase | Phase 2 |
What the finished NCT00083421 record still lists
NCT00083421 is an interventional study that assigns participants to a tested intervention. The registered 647 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (386% higher).
The record links to 0 conditions, and to 1 intervention - of which ONO-2506PO is the first listed.
NCT00083421 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00083421 about?
NCT00083421 is a clinical study titled "Effects of ONO-2506PO in Patients With Alzheimer's Disease". The purpose of this study is to establish the presence of an effect of treatment with ONO-2506PO in patients with Alzheimer's Disease, based upon cognitive and global scales.
What is the current status of trial NCT00083421?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 647 participants. The study started on 2004-06. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00083421?
The interventions under investigation include: ONO-2506PO (DRUG).
Who is sponsoring clinical trial NCT00083421?
This trial is sponsored by Ono Pharma USA, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00083421's enrollment target sits among peer trials
647 50th of 2000 higher than 1,951 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07027306 · 648 participants
The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures
- NCT07164456 · 648 participants · NA
Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers
- NCT04863222 · 646 participants · Phase 4
Clinical and Radiographic Success of MTA vs Biodentine
- NCT07012395 · 645 participants · Phase 2
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia